Stilbenes: chemistry and pharmacological properties
Keywords:Stilbene, Chemistry, Structures, Biosynthesis pathway, Pharmacological properties
Medicinal plants are the most important source of life saving drugs for the majority of the Worlds’ population. The compounds which synthesized in the plant from the secondary metabolisms are called secondary metabolites; exhibit a wide array of biological and pharmacological properties. Stilbenes a small class of polyphenols, have recently gained the focus of a number of studies in medicine, chemistry as well as have emerged as promising molecules that potentially affect human health. Stilbenes are relatively simple compounds synthesized by plants and deriving from the phenyalanine/ polymalonate route, the last and key enzyme of this pathway being stilbene synthase. Here, we review the biological significance of stilbenes in plants together with their biosynthesis pathway, its chemistry and its pharmacological significances.
Ramawat KG, Sonie KC, Sharma MC. Therapeutic Potential of Medicinal Plants: An Introduction. In: Biotechnology of Medicinal Plants, Vitalizer and Therapeutic. Ramawat KG (ed.) Sci. Pub., Inc., USA. 2004 ; pp 1-18
Baur J, Sinclair DA Therapeutic potential of resveratrol: the invivo evidence. Nat. Rev. Drug Disc. 2006 ;5 : 493–506
Opie LH, Lecour S The red wine hypothesis : from concept to protective signalling molecules. Eoropean heart Journal 2007 ;28 :1683-1693
Martinez-Marquez A, Jaime A. Carriel M, Estrada KM, Cusido RM,Palazonand J, Martınez RB. Production of highly bioactive resveratrol analogues pterostilbene and piceatannol in metabolically engineered grapevine cell cultures. Plant Biotech. J. 2016; 14:1813-1825.
Szekeres, T., Saiko, P., Fritzer-Szekeres, M., Djavan, B, Jager, W. Chemopreventive effects of resveratrol and resveratrol analogues.AnnalsN.Y. Acad. Sci. 2011; 1215:89–95.
Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, Brasure J, Merletti F, Boyle P. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol. 1995 ;31:181–187
Longnecker, MP, Newcomb PA, Mittendorf R, Greenberg ER, Clapp RW, Bogdan GF, Baron J, MacMahon B, Willett, WC. Risk of breast cancer in relation to lifetime alcohol consumption. Journal of the National Cancer Institute 1995; 87: 923-929
Sotheeswaran S and Pasupathy V. “Distribution of resveratrol oligomers in plants,” Phytochemistry 1993 ; 32:1083-1092
Goldberg DM, Ng E, Karumanchiri A, Diamandis EP, Soleas GJ. Resveratrol glucosides are important components of commercial wines. Am J Enol Vitic 1996; 47:415-420
Waffo-Teguo P, Krisa S, Richard T and Merillon JM. Grapevine Stilbenes and their biological effects. In: Bioactive molecules and medicinal plants. 2008; Springer, Heidelberg. pp 24-55
Decendit A, Waffo-Téguo P, Richard T, Krisa S, Vercauteren J, Monti JP, Deffieux G, Mérillon JM.Galloylated catechins and stilbenes diglucosides in Vitis Vinifera cell suspension cultures. Phytochemistry 2000;60:795-798
Larronde F, Richard T, Delaunay JC, Decendit A, Monti JP, Krisa S, Merillon JM.New stilbenoid glucosides isolated from Vitis vinifera cell suspension cultures (cv. Cabernet Sauvignon). Planta Med 2005 ; 71:888-890
Baderschneider B, Winterhalter P.Isolation and characterization of novel stilbenes derivatives from Riesling wine. J. Agric. Food Chem 2000 ;48 : 2681-2686
Waffo-Teguo P, Lee D, Cuendet M, Merillon J, Pezzuto JM, Kinghorn AD Two new stilbene dimer glucosides from grape (Vitis vinifera) cell cultures. J Nat Prod 2001 ; 64: 136-8
Ito J, Niwa M, Oshima Y. A new hydroxystilbene tetramer named isohopeaphenol from Vitis vinifera ‘Kyohou' [J]. Heterocycles 1997 ; 45 :1809-1813
Jean-Denis JB, Pezet R. and Tabacchi R. Rapid analysis of stilbenes and derivatives from downy mildew-infected grapevine leaves by liquid chromatography-atmospheric pressure photoionisation mass spectrometry. J. Chromatogr. A 2006 ;1112 : 263-268
Romero-Perez AI, Ibern-Gomez M, Lamuela-Raventos RM, de la Torre-Boronat MC. Piceid, the major resveratrol derivative in grape juices. J Agric Food Chem 1999; 47:1533-6.32.
Decendit A, Waffo-Téguo P, Richard T, Krisa S, Vercauteren J, Monti JP, Deffieux G, Mérillon. Galloylated catechins and stilbenes diglucosides in Vitis Vinifera cell suspension cultures. Phytochemistry 2002; 60:795-798
Vitrac, X., Krissa, S., Decendit, A., Deffieux, G., Merillon, J.M. Grapevine polyphenols and their biological effects. In: Biotechnology of medicinal plants. 2004; Ramawat, K.G. (ed.) Sci. Pub. Enfield, USA. pp 3
Vitrac X, Bornet A, Vanderlinde R, Valls Josep, Richard T, Delaunay JC, Mérillon JM, Teissèdre PL (2005). Determination of stilbenes (delta-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, epsilon-viniferin) in Brazilian wines. J. Agr Food Chem 53:5664-9
Andlauer W, Kolb J, Siebert K, Fürst P. Assessment of resveratrol bioavailability in the perfused rat small intestine. Drugs Exp. Clin. Res 2000 ; 26:47-55
Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther 2002 ; 302: 369-373
Yu KW, Gao WY, Hahn EJ and Paek KY. Jasmonic acid improves ginsenoside accumulation in adventitious root culture of Panax ginseng C.A. Meyer. Biochemical Engineering Journal vol 2002 ; 11:211-215
Halliwell B. Free radicals and antioxidants: a personal view. Nutr. Rev. 1995 ;52:253-265
Delmas D, Lancon A, Colin D, Jannin B, Latrufe N. Resveratrol as a chemopreventive agent : a promising molecule for fighting cancer. Curr Drug Targets 2006; 7:423-442
Auger C, Teissèdre PL, Gérain P, Lequeux N, Bornet A, Serisier S, Besançon P, Caporiccio B, Cristol JP, Rouanet JM. J Agr Food Chem 2005 ; 53 : 2015
Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995;. 91:1182–1188
Kinghorn AD, Fong HHS, Farnsworth NR, Mehta RG, Moon RC, Moriarty RM, Pezzuto JM. Cancer chemopreventive agents discovered by activity guided fractionation: a review. Curr Org Chem 1998; 2: 597-612
Alberts DS, Colvin OM, Conney AH, Ernster VL, Garber JE, Greenwald P. Prevention of cancer in the next millennium: Report of chemoprevention working group to the American Association for Cancer Research. Cancer Res 1999 ; 59:4743–4758
Lanzilli G, Fuggetta MP, Tricarico M, Cottarelli A, Serafino A, Falchetti R, Ravagnan G, Turriziani M, Adamo R, Franzese O, Bonmassar E Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol. 2006 ;28:641-8
Jang M, Pezzuto JM Cancer chemopreventive activity of resveratrol Drug. Exp Clin Res 1999; 25 : 65-77
Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases, a review of their intracellular targets. Eur J Pharmacol 2006 ;545:51-64
Gao ZB, Hu GY (2005) Brain Res 1056: 68Geerlings A. Strictosidine β-Dglucosidasean enzyme in the biosynthesis of pharmaceutically important in dole alkaloids. 1999 ; Ph.D. Thesis, University of Leiden, The Netherlands (117p)
Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri T. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005 ; 37:349–50
Wang Q, Xu J, Rottinghause GE, Simonyi A, Lubhan D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerblis brain. Brain Res 2002; 958:439-447
How to Cite
Copyright (c) 2020 Chetana Roat, Meenu Saraf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.